Maruja Lira,
Senior Scientist,
Pfizer Inc
Maruja Lira is a senior scientist within Precision Medicine group at Pfizer oncology research unit. Her current focus is on identification of patient selection biomarkers through genomic molecular profiling efforts. She has extensive technical experience in analysis of gene expression, copy number, mutation detection, and next generation sequencing. She is a key developer of a transcript-based assay for screening ALK, ROS1, and RET fusions in lung cancer.
|
|
|
Add to Calendar ▼2013-09-12 17:15:002013-09-12 18:15:00Europe/LondonALK, ROS1 and RET Fusion Detection in Lung CancerPoint-of-Care Diagnostics World Congress 2013 in San Diego, CA, USASan Diego, CA, USASELECTBIOenquiries@selectbiosciences.com
